About the program
Obesity in children and adolescents is at an all-time high. Adolescent obesity is likely to persist into adulthood, where it has more severe lifelong impact than adult-onset obesity, including a high risk of chronic comorbidities such as type 2 diabetes (T2D) and chronic kidney disease (CKD), alongside psychological distress.
Younger age at intervention is associated with improved long-term outcomes and a reduction in cardiometabolic risk, however compared with children, adolescents have a 41% lower chance of successful weight loss and maintenance, emphasizing the need for early, proactive, and sustained intervention and management.
The advent of anti-obesity medications (AOMs) has begun to close the gap between lifestyle intervention alone and bariatric surgery in terms of long-term weight management. With some of these AOMs now indicated in the adolescent population, we need to ensure the right people are benefiting from them.
This expert-led program aims to support you with the individualized management of obesity in adolescents through education on:
- the importance of early detection and intervention;
- how to develop tailored management plans including the appropriate incorporation of AOMs; and
- managing the psychological and social factors influencing treatment adherence.
Learning objectives
Following completion of this independent educational program, you will be able to:
- Describe the chronic burden of obesity in adolescent and need for proactive intervention
- Integrate pharmacological therapies alongside lifestyle interventions, where appropriate
- Develop strategies to support individualized management strategies based on patient motivators and barriers
Target audience
This program is aimed at an international audience of non-US and non-UK obesity specialists, pediatric endocrinologists and those treating adolescent patients with obesity.
Endorsement
ECOG endorses and supports the continuing medical educational program “Rethinking obesity in adolescents”.
Planning Committee
In addition to the expert faculty Springer Healthcare IME planners and staff include Rachel Goddard, Rebecca Cox and James Hutton. The Planning Committee have no financial relationships to disclose.
All relevant financial relationships of the Faculty have been mitigated.
